Summary
The sophistication of Hadron facilities led to major technical and conceptual advances in the treatment immobilization, reproducability, planning and execution. Some of these developments have had a pivotal impact on conventional treatments, which can now approach the dose localization advantage of protons in the majority of clinical situations. While the biological advantages of neutrons may finally be combined with excellent dose localization in Heavy Ion Facilities, modern surgical or systemic treatment methods may reduce high LET advantages. Clinical trials still need to define the relative merits of these approaches in their most modern implentation. The advantage gap has certainly been narrowed by recent developments in conventional therapy.
References
Advani SJ, Chmura SJ, Weichselbaum. Radiogenic Therapy: On the Interaction of Viral Therapy and Ionizing Radiation for Improving Local Control of Tumors. Sem Oncol 1997;24:633–8.
Corn BW, Curran WJ Jr, Shrieve DC, et al. Stereotactic radiosurgery and radiotherapy: New developments and new directions. Sem Oncol 1997; 24:707–14.
Laramore GE. The use of neutrons in cancer therapy: A historical perspective through the modern era. Sem Oncol 1997;24:672–87.
Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Sem Oncol 1997;24:686–95.
Purdy JA. Advances in three-dimensional treatment planning and conformal dose therapy. Sem Oncol 1997;24:655–71.
Stitt JA, Thomadsen BR. Innovations and advances in brachytherapy. Sem Oncol 1997;24:696–706.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gahbauer, R.A. A challenge for high-precision radiation therapy: The case for photons. Strahlenther Onkol 175 (Suppl 2), 121–122 (1999). https://doi.org/10.1007/BF03038910
Issue Date:
DOI: https://doi.org/10.1007/BF03038910